Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Inventory (2020 - 2025)

Oncology Institute (TOI) has disclosed Inventory for 6 consecutive years, with $18.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Inventory rose 86.84% year-over-year to $18.9 million, compared with a TTM value of $18.9 million through Sep 2025, up 86.84%, and an annual FY2024 reading of $10.0 million, down 26.6% over the prior year.
  • Inventory was $18.9 million for Q3 2025 at Oncology Institute, up from $15.8 million in the prior quarter.
  • Across five years, Inventory topped out at $18.9 million in Q3 2025 and bottomed at $6.4 million in Q4 2021.
  • Average Inventory over 5 years is $11.3 million, with a median of $10.8 million recorded in 2023.
  • The sharpest move saw Inventory decreased 26.6% in 2024, then surged 86.84% in 2025.
  • Year by year, Inventory stood at $6.4 million in 2021, then soared by 43.85% to $9.3 million in 2022, then surged by 47.69% to $13.7 million in 2023, then decreased by 26.6% to $10.0 million in 2024, then soared by 88.09% to $18.9 million in 2025.
  • Business Quant data shows Inventory for TOI at $18.9 million in Q3 2025, $15.8 million in Q2 2025, and $12.3 million in Q1 2025.